We are live on ! Find out more
KPRX icon

Kiora Pharmaceuticals
KPRX

14 hedge funds and large institutions have $5.57M invested in Kiora Pharmaceuticals in 2019 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

202% more capital inflows, than outflows

Capital inflows: $272K | Capital outflows: $90.1K

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

8% more funds holding

Funds holding: 13 → 14 (+1)

0.59% more ownership

Funds ownership: 41.13% → 41.73% (+0.59%)

50% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 4

Holders
14
Holders Change
+1
Holders Change %
+7.69%
% of All Funds
0.3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
2
Reduced
4
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Armistice Capital
Armistice Capital
New York
+$248K
2
Advisor Group
Advisor Group
Arizona
+$9.7K
3
Virtu Financial
Virtu Financial
New York
+$2.43K

Top Sellers

Rank Fund Capital Flow
1
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$41.3K
2
Citadel Advisors
Citadel Advisors
Florida
-$22K
3
Panagora Asset Management
Panagora Asset Management
Massachusetts
-$14.6K
4
UBS Group
UBS Group
Switzerland
-$9.7K
5
Wedbush Securities
Wedbush Securities
California
-$2.43K

KPRX Hedge Fund Activity: Q1 2019 in Review

14 of the 4,634 institutional investors tracked by Wall St. Rank reported a position in Kiora Pharmaceuticals (KPRX) for Q1 2019, worth a combined $5.57M — down 33% from $8.31M a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new KPRX positions and 1 closed out — a net gain of 1 holder — while 2 added to existing stakes and 4 trimmed.

The largest buyer was Armistice Capital, adding an estimated $248K. The largest seller was Acadian Asset Management, cutting an estimated $41.3K.

  • 14 institutional investors held Kiora Pharmaceuticals (KPRX) as of Q1 2019, up from 13 in Q4 2018.
  • Funds reported $5.57M of Kiora Pharmaceuticals stock for Q1 2019, down 33% quarter-over-quarter.
  • 2 funds opened new Kiora Pharmaceuticals positions in Q1 2019 and 1 closed out, a net change of +1 holder.
  • The largest Kiora Pharmaceuticals buyer in Q1 2019 was Armistice Capital, an estimated $248K added.
  • The largest Kiora Pharmaceuticals seller in Q1 2019 was Acadian Asset Management, an estimated $41.3K sold.

Based on aggregated 13F filings for Q1 2019.